实施静脉血栓栓塞指南与电子健康记录医嘱套餐对创伤患者静脉血栓栓塞发生率的影响:一项多中心研究
该多中心回顾性研究纳入2018年7月至2021年12月3家创伤中心收治的15岁及以上创伤患者共12,479例,排除烧伤、再入院、住院<2天及撤除治疗者。2020年11月实施基于出血风险的VTE临床实践指南(推荐更早启动化学预防、优先选用低分子肝素)及EHR医嘱套餐,比较实施前后VTE发生率。结果显示实施后组LMWH使用率更高(64.0 vs 67.5%,p<0.01)、未预防比例更低(17.2 vs 12.5%,p<0.01)、预防启动时间更短(29.4 vs 25.9小时,p<0.01),VTE(1.6 vs 1.0%,p<0.01)与深静脉血栓(1.1 vs 0.7%,p=0.03)发生率均降低,肺栓塞无差异(0.6 vs 0.4%,p=0.06)。单因素分析实施后组死亡率更高(0.7 vs 1.1%,p=0.03),校正分析后无差异。结论认为实施全院VTE指南与EHR医嘱套餐与创伤患者VTE发生率降低相关,且死亡率无差异。
要点
- 实施VTE指南与EHR医嘱套餐后,创伤患者VTE发生率由1.6%降至1.0%(p<0.01),深静脉血栓由1.1%降至0.7%(p=0.03)。
- 实施后组LMWH使用率由64.0%升至67.5%(p<0.01),未接受预防比例由17.2%降至12.5%(p<0.01),预防启动时间由29.4小时缩短至25.9小时(p<0.01)。
- 肺栓塞发生率实施前后无差异(0.6 vs 0.4%,p=0.06)。
- 单因素分析实施后组死亡率更高(0.7 vs 1.1%,p=0.03),但校正分析后两组无差异。
- VTE的独立预测因素包括预防启动时间更长、损伤严重度评分更高、呼吸机相关性肺炎及住院时间更长;使用LMWH与实施后时期为VTE的保护因素。
适用人群与场景
- 2018年7月至2021年12月收治于3家创伤中心的15岁及以上创伤患者。
- 排除标准:烧伤、再入院、住院时间<2天及撤除治疗。
处置流程与药物剂量
- VTE临床实践指南基于出血风险提供推荐,推荐更早启动化学预防,并优先选用低分子肝素(LMWH)。
- 配套实施基于电子健康记录(EHR)的VTE预防医嘱套餐。
研究设计与关键结果
- 研究类型:多中心回顾性研究,纳入3家创伤中心12,479例创伤患者,比较VTE指南与EHR医嘱套餐实施前(pre)与实施后(POST)的变化。
- 实施后组LMWH使用率更高(64.0 vs 67.5%,p<0.01),未接受预防比例更低(17.2 vs 12.5%,p<0.01),预防启动时间更短(29.4 vs 25.9小时,p<0.01)。
- 实施后组VTE发生率更低(1.6 vs 1.0%,p<0.01),深静脉血栓发生率更低(1.1 vs 0.7%,p=0.03)。
- 两组肺栓塞发生率无差异(0.6 vs 0.4%,p=0.06)。
- 单因素分析实施后组死亡率更高(0.7 vs 1.1%,p=0.03),校正分析后两组无差异。
- VTE的独立预测因素为预防启动时间更长、损伤严重度评分更高、呼吸机相关性肺炎及住院时间更长;使用LMWH与实施后时期为VTE的保护因素。
证据类型、等级与局限
- 证据类型:多中心回顾性研究;证据等级:预后与流行病学,Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 实施基于出血风险的VTE临床实践指南及EHR医嘱套餐,与创伤患者VTE发生率降低相关(1.6 vs 1.0%,p<0.01),且死亡率无差异。
- 指南推荐更早启动化学预防并优先选用LMWH,实施后LMWH使用率由64.0%升至67.5%(p<0.01),未预防比例由17.2%降至12.5%(p<0.01)。
- 作者结论认为实施全院VTE指南与EHR医嘱套餐与创伤患者VTE发生率降低相关,且死亡率无差异。
指南或共识出处
- 静脉血栓栓塞临床实践指南(VTE CPG)及基于电子健康记录的VTE预防医嘱套餐,于2020年11月实施;具体指南名称与发布机构原文未提及。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Appropriate chemical prophylaxis can reduce the risk of venous thromboembolism (VTE) in trauma patients. A system-wide VTE clinical practice guideline (CPG) and electronic health record (EHR)-based VTE prophylaxis order set were implemented. The CPG provided guidelines based on bleeding risk, recommended earlier initiation of chemical prophylaxis, and favored low-molecular-weight heparin (LMWH). The purpose of this study was to evaluate the impact of VTE CPG and prophylaxis order set on the rate of VTE.
METHODS: A retrospective review was performed on trauma patients 15 years or older admitted to three trauma centers between July 2018 and December 2021. Exclusion criteria included burn injury, readmission, length of stay <2 days, and withdrawal of care. The VTE CPG and EHR order set were implemented in November 2020, and a pre-implementation/postimplementation (POST) comparison was conducted.
RESULTS: A total of 12,479 patients were included. There were no differences in age, sex, and Injury Severity Score. The POST group had a higher usage of LMWH (64.0 vs. 67.5%, p < 0.01), a lower rate of no prophylaxis (17.2 vs. 12.5%, p < 0.01), and a shorter time to prophylaxis (29.4 vs. 25.9 hours, p < 0.01). The rates of VTE (1.6 vs. 1.0%, p < 0.01) and deep vein thrombosis (1.1 vs. 0.7%, p = 0.03) were lower in the POST group. There was no difference in the rate of pulmonary embolism (0.6 vs. 0.4%, p = 0.06). The POST group had a higher mortality (0.7 vs. 1.1%, p = 0.03) on univariable analysis, but there were no differences between groups on adjusted analysis. Independent predictors of VTE were longer time to VTE prophylaxis, higher Injury Severity Score, ventilator-associated pneumonia, and longer hospital length of stay. Use of LMWH and postintervention period were protective from VTE.
CONCLUSIONS: The implementation of a system-wide VTE CPG and EHR-based prophylaxis order set were associated with a reduced incidence of VTE in trauma patients without an associated mortality difference.
LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level IV.
参考来源
- Lee JS, Johnson E, Schmoekel NH, et al. Impact of implementing a venous thromboembolism guideline and electronic health records order set on venous thromboembolism rates in trauma patients: A multicenter study. J Trauma Acute Care Surg. 2025. PMID: 40232170. doi:10.1097/TA.0000000000004628
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。